Literature DB >> 12359834

Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease.

Kevin A Corcoran1, Ye Lu, R Scott Turner, Stephen Maren.   

Abstract

One of the hallmarks of the pathology in Alzheimer's disease is the deposition of amyloid plaques throughout the brain, especially within the hippocampus and amygdala. Transgenic mice that overexpress the Swedish mutation of human amyloid precursor protein (hAPPswe; Tg2576) show age-dependent memory deficits in hippocampus-dependent learning tasks. However, the performance of aged Tg2576 mice in amygdala-dependent learning tasks has not been thoroughly assessed. We trained young (2-4 mo) and old (16-18 mo) Tg2576 and wild-type mice in a T-maze alternation task (hippocampus-dependent) and a Pavlovian fear-conditioning task (amygdala- and hippocampus-dependent). As previously reported, old Tg2576 mice showed impaired acquisition of rewarded alternation; none of these mice reached the criterion of at least five out of six correct responses over three consecutive days. In contrast, old Tg2576 mice showed normal levels of conditional freezing to an auditory conditional stimulus (CS) and acquired a contextual discrimination normally. However, when the salience of the fear-conditioning context was decreased, old (12-14 mo) Tg2576 mice were impaired at acquiring fear to the conditioning context, but not to the tone CS. Histological examination of a subset of the mice verified the existence of amyloid plaques in the cortex, hippocampus, and amygdala of old, but not young, Tg2576 mice. Hence, learning and memory deficits in old Tg2576 mice are limited to hippocampus-dependent tasks, despite widespread amyloid deposition in cortex, hippocampus, and amygdala.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359834      PMCID: PMC187133          DOI: 10.1101/lm.51002

Source DB:  PubMed          Journal:  Learn Mem        ISSN: 1072-0502            Impact factor:   2.460


  60 in total

1.  Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease.

Authors:  C L Grady; M L Furey; P Pietrini; B Horwitz; S I Rapoport
Journal:  Brain       Date:  2001-04       Impact factor: 13.501

2.  The origins of Alzheimer disease: a is for amyloid.

Authors:  D J Selkoe
Journal:  JAMA       Date:  2000 Mar 22-29       Impact factor: 56.272

3.  Amygdala, hippocampus and discriminative fear conditioning to context.

Authors:  E A Antoniadis; R J McDonald
Journal:  Behav Brain Res       Date:  2000-02       Impact factor: 3.332

Review 4.  Alzheimer's disease in man and transgenic mice: females at higher risk.

Authors:  R S Turner
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

5.  Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.

Authors:  R G Phillips; J E LeDoux
Journal:  Behav Neurosci       Date:  1992-04       Impact factor: 1.912

6.  Conditioning and contextual retrieval in hippocampal rats.

Authors:  M Good; R C Honey
Journal:  Behav Neurosci       Date:  1991-08       Impact factor: 1.912

7.  Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins.

Authors:  Kelly T Dineley; Xuefeng Xia; Duy Bui; J David Sweatt; Hui Zheng
Journal:  J Biol Chem       Date:  2002-03-23       Impact factor: 5.157

8.  Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits.

Authors:  A Stéphan; S Laroche; S Davis
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

9.  Memory enhancement for emotional stimuli is impaired in early Alzheimer's disease.

Authors:  S B Hamann; E S Monarch; F C Goldstein
Journal:  Neuropsychology       Date:  2000-01       Impact factor: 3.295

10.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

View more
  42 in total

Review 1.  Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

Authors:  Marcello Leopoldo; Enza Lacivita; Francesco Berardi; Roberto Perrone; Peter B Hedlund
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

2.  Preserved fronto-striatal plasticity and enhanced procedural learning in a transgenic mouse model of Alzheimer's disease overexpressing mutant hAPPswe.

Authors:  Silvia Middei; Raffaella Geracitano; Antonio Caprioli; Nicola Mercuri; Martine Ammassari-Teule
Journal:  Learn Mem       Date:  2004 Jul-Aug       Impact factor: 2.460

3.  Longitudinal brain corticotropin releasing factor and somatostatin in a transgenic mouse (TG2576) model of Alzheimer's disease.

Authors:  Jennifer Horgan; Jose Javier Miguel-Hidalgo; Martha Thrasher; Garth Bissette
Journal:  J Alzheimers Dis       Date:  2007-09       Impact factor: 4.472

4.  Memory deficits are associated with impaired ability to modulate neuronal excitability in middle-aged mice.

Authors:  Catherine C Kaczorowski; John F Disterhoft
Journal:  Learn Mem       Date:  2009-05-23       Impact factor: 2.460

Review 5.  Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer's Disease and Dementia.

Authors:  A Shepherd; S Tyebji; A J Hannan; E L Burrows
Journal:  J Mol Neurosci       Date:  2016-09-16       Impact factor: 3.444

Review 6.  Metallothionein and brain inflammation.

Authors:  Yasmina Manso; Paul A Adlard; Javier Carrasco; Milan Vašák; Juan Hidalgo
Journal:  J Biol Inorg Chem       Date:  2011-06-16       Impact factor: 3.358

7.  Impaired rapid eye movement sleep in the Tg2576 APP murine model of Alzheimer's disease with injury to pedunculopontine cholinergic neurons.

Authors:  Bin Zhang; Sigrid C Veasey; Marcelo A Wood; Lewis Z Leng; Christine Kaminski; Susan Leight; Ted Abel; Virginia M-Y Lee; John Q Trojanowski
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

8.  Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment.

Authors:  Bing Gong; Ottavio V Vitolo; Fabrizio Trinchese; Shumin Liu; Michael Shelanski; Ottavio Arancio
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 9.  Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.

Authors:  Daniela Puzzo; Linda Lee; Agostino Palmeri; Giorgio Calabrese; Ottavio Arancio
Journal:  Biochem Pharmacol       Date:  2014-01-21       Impact factor: 5.858

10.  The S-adenosyl homocysteine hydrolase inhibitor 3-deaza-adenosine prevents oxidative damage and cognitive impairment following folate and vitamin E deprivation in a murine model of age-related, oxidative stress-induced neurodegeneration.

Authors:  Thomas B Shea; David Ashline; Daniela Ortiz; Shelia Milhalik; Eugene Rogers
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.